Home/Filings/4/0001140361-19-002080
4//SEC Filing

Nolan Lisa 4

Accession 0001140361-19-002080

CIK 0001228627other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 7:48 AM ET

Size

4.7 KB

Accession

0001140361-19-002080

Insider Transaction Report

Form 4
Period: 2019-01-30
Nolan Lisa
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2019-01-30$0.65/sh+20,000$12,96021,625 total
Footnotes (1)
  • [F1]The price of $0.648 per share represents a weighted average of purchase prices ranging from $0.635 to $0.650 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001661400

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 7:48 AM ET
Size
4.7 KB